Background Cancer creates considerable challenges for China with its aging population.
This analysis aimed to estimate the burden of cancer and transition in cancer spectrum …

The first prophylactic vaccine against human papillomavirus (HPV) 16 and HPV18 was
licensed in Japan in 2009. HPV vaccine effectiveness against high‐grade cervical lesions …

INTRODUCTION—Human papillomavirus (HPV) is a sexually transmitted pathogen that
causes anogenital and oropharyngeal disease in males and females. Persistent viral …

Abstract Background Kidney transplant recipients (KTRs) have increased risk of human
papillomavirus (HPV)‐related cancers, including cervical and anal cancer. In this cross …

To the Editor The Japanese government resumed proactive recommendation of human
papillomavirus (HPV) vaccination in April 2022 and has recently decided to introduce the 9 …

In November 2021, the government of Japan announced a reversal of its decision in 2013 to
suspend the previous proactive recommendation for HPV vaccination. However, the …

Objective The aim of the study was to describe trends in cervical cancer screening and
outcomes for women under 25 years of age in Belgium between 2010 and 2019 in response …

Cervical cancer is the first cancer deemed amenable to elimination through prevention, and
thus lessons from the epidemiology and prevention of this cancer type can provide …

The preventive effect of HPV vaccines against anogenital and oropharyngeal cancers has
been proven in both clinical trials and real-world data. We reviewed the published evidence …

Human papillomavirus (HPV) is associated with benign and malignant lesions in various
locations, such as the skin and oral and genital mucosa [1]. Indeed, HPV is the most …